US pharma tariffs a headline risk for Sun Pharma: Report
New Delhi, Sep 26 (IANS) The United States’ decision to impose a 100 per cent tariff on imports of patented drugs from October 1 has raised concerns for Sun Pharma, a new report said on Friday.